olaparib,bevacizumab
Merck,roche,AstraZeneca
['olaparib']
 looks like paola with olaparib + bev. failure for desirable cross-over in control-arm should imo not be allowed to be just in the small corner of the km-curve. should be realy big. 
75% gynecological oncologist Västerås ????. 25% HTA-unit Camtö Örebro Hospital. Views my own. Words matter. Dislike lifscience like QoL&D engl, swed, germ